Easium

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Easium

What is Easium?

Easium is a pharmaceutical medication containing the active substance lormetazepam. It belongs to a class of drugs known as benzodiazepines, which are characterized by their effects on the central nervous system. Specifically, lormetazepam is categorized as a short-to-intermediate acting benzodiazepine derivative.

Therapeutic Use

This medication is primarily used for the short-term treatment of insomnia. It is indicated for patients experiencing significant sleep disturbances, including:

  • Difficulty falling asleep (sleep onset insomnia)
  • Frequent nocturnal awakenings
  • Early morning awakening

By interacting with specific receptors in the brain, the medication helps to decrease the time it takes to fall asleep and increases the total duration of sleep.

Mechanism of Action

Easium works by enhancing the activity of gamma-aminobutyric acid (GABA), a naturally occurring chemical messenger in the brain. GABA is an inhibitory neurotransmitter, meaning it reduces the activity of neurons. By reinforcing these inhibitory effects, the medication induces a state of sedation, muscle relaxation, and anxiolysis (reduction of anxiety), which facilitates the onset and maintenance of sleep.

Clinical Considerations

As with other medications in the benzodiazepine class, Easium is intended for short-term use. Chronic or long-term administration is generally avoided to prevent changes in the body's response to the medication. It is typically reserved for cases where the sleep disorder is severe, disabling, or causing the individual extreme distress.

Regulatory References

  1. National Institutes of Health (NIH)

What side effects are possible with Easium?

Possible Side Effects and Safety Information

Easium's safety profile is officially documented and categorized by regulatory bodies based on clinical trial data and post-marketing surveillance. This information structures the understanding of the medicine's risks.


Adverse Reactions Scope

The most common adverse reactions reported include somnolence (drowsiness), dizziness, ataxia (loss of coordination), confusion, and fatigue. These frequently reported effects primarily involve the Nervous System Disorders and Psychiatric Disorders system-organ classes.

Less common but documented adverse reactions include paradoxical reactions (e.g., excitement, agitation), anterograde amnesia (difficulty forming new memories), and the development of physical or psychological dependence with prolonged use.

Serious Safety Considerations

Official regulatory documents classify several effects as serious, including respiratory depression, severe hypersensitivity reactions (e.g., anaphylaxis, angioedema), and the potential for suicidal ideation/behavior. The risk of profound Central Nervous System (CNS) depression is particularly noted in the context of overdosage or co-administration with other depressants.

Safety Restrictions and Special Populations

Contraindications (situations where the drug is prohibited) include known hypersensitivity to the drug class, myasthenia gravis, severe respiratory insufficiency, and severe hepatic impairment.

Regulatory warnings note specific risks for certain populations: Geriatric patients require lower starting doses due to increased sensitivity to CNS effects, and use during pregnancy is officially categorized with documented risk (e.g., Category D) due to potential fetal harm, while excretion into breast milk may cause sedation in the nursing infant.

Exposure Patterns

Official safety information highlights that dependence and withdrawal symptoms are associated with prolonged administration or abrupt cessation, often requiring gradual discontinuation to manage the associated risks, which can include rebound insomnia or anxiety. This structures how the drug's use over time is officially viewed.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Easium (Diazepam) is officially documented by regulatory authorities as a progressive form of Central Nervous System (CNS) Depression. Symptoms may range from mild effects like somnolence, lethargy, and confusion to more severe clinical manifestations, including slurred speech, ataxia (loss of coordination), and diminished reflexes.

When to Seek Immediate Medical Help

The regulatory guidance mandates that you seek medical help right away for any suspected overdose. Call emergency services immediately if a person exhibits severe symptoms such as profound sedation, trouble breathing, or inability to be awakened. Life-threatening outcomes, including respiratory depression, apnea, cardiac arrest, and death, are officially recognized risks, particularly when Easium is combined with other CNS depressants like opioids.

Management and Monitoring

The management described in regulatory labels is primarily symptomatic and supportive treatment, focusing on close observation and continuous monitoring of vital signs. While the reversal agent Flumazenil exists, its use is associated with a specific regulatory warning about the potential to precipitate seizures or acute withdrawal reactions.

Therapeutic Uses of Easium

Quick Facts

  • Support for Anxiety: May help manage anxiety disorders and provide short-term relief for symptoms of anxiety.
  • Relief for Withdrawal: Used in a supportive role for the symptomatic relief of acute alcohol withdrawal.
  • Adjunct for Seizures: Used alongside other therapies for managing certain types of seizure disorders.
  • Skeletal Muscle Support: May be used as an adjunct for the relief of skeletal muscle spasms.

Easium is a prescription treatment that may be prescribed for several distinct conditions. Its primary therapeutic domains involve the central nervous system, where it is believed to act on the GABA neurotransmitter pathway.

It is formally indicated for the management of anxiety disorders and the short-term relief of anxiety symptoms, and may contribute to a reduction in tension associated with these states. In a hospital setting, Easium is often utilized as an adjunct treatment for symptoms related to acute alcohol withdrawal, including agitation and tremor, to provide necessary symptomatic relief.

The medication is also a useful therapy for the relief of skeletal muscle spasms, whether those spasms are due to local injury, inflammation, or spasticity linked to upper motor neuron disorders. Furthermore, Easium may serve as a valuable ancillary treatment for certain seizure disorders. This medication is used strictly under the direction of a healthcare professional.

Eligibility and Restrictions for Use

Who can and cannot use Easium?

The official eligibility profile for Easium (Diazepam) is strictly defined by regulatory authorities and determines the specific populations allowed to use the medicine.


Populations and Conditions for Use

Category Official Regulatory Status
Use is Contraindicated Patients with known hypersensitivity to diazepam or other benzodiazepines. Contraindications include severe hepatic insufficiency, myasthenia gravis, sleep apnea syndrome, severe respiratory insufficiency, and acute narrow-angle glaucoma.
Age Thresholds Use is contraindicated in children under 6 months of age (oral forms). Safety and efficacy have not been established in neonates (30 days or less) for injectable forms.
Older Adults Individuals over 65 require special caution and monitoring due to an increased risk of accumulation and central nervous system effects.
Conditional Use Patients with mild to moderate hepatic impairment, renal impairment, or a history of alcohol/drug abuse must use the medicine with extreme caution and regulatory oversight.
Pregnancy/Lactation Classified as former Pregnancy Category D (evidence of fetal risk). Not recommended for regular use during lactation, as the drug is excreted into breast milk.

Regulatory documents define who can and cannot use Easium by establishing absolute contraindications for specific diseases and age groups. Eligibility is further structured by conditional use requirements for patients with compromised organ function or a history of substance abuse. Use in pregnant and breastfeeding populations is generally not recommended or limited due to documented risks.

What should I know about interactions with other medicines?

Easium, which contains the active substance diazepam, may interact with several other medicines and substances. These interactions can potentially increase the side effects of Easium, such as drowsiness and impaired coordination, or affect how well the other medication works. It is important to discuss all medicines you are taking, including over-the-counter drugs and herbal supplements, with your healthcare provider.

Significant Drug Interactions

Co-administering Easium with certain medicines can significantly increase its central nervous system (CNS) depressant effects, leading to pronounced drowsiness, respiratory depression, and even coma. These medicines include:

  • Opioids: Pain relief medications such as hydrocodone or oxycodone.
  • Other CNS Depressants: Medicines like antipsychotics, other sedatives, hypnotics, certain antidepressants, and antihistamines.
  • Antifungal Agents: Medicines such as ketoconazole or fluconazole, which can slow down the breakdown of Easium in the body.
  • Anticoagulants: Increased monitoring of the effects of blood thinners, such as warfarin, may be necessary as Easium can potentially alter their levels.

Other Interactions

  • Alcohol: The concomitant use of Easium and alcohol is strongly discouraged. Alcohol's sedative effects are significantly increased by Easium, which can lead to severe drowsiness, breathing difficulties, and profound impairment of judgment and motor control.
  • Herbal Products: Avoid using the herbal remedy St. John's Wort as it can decrease the effectiveness of Easium.

Mechanism of Action

Targeted Modulation of the X-Receptor System

Easium primarily acts on defined biological targets, specifically the X-receptor complex, where it functions as a positive allosteric modulator (PAM). This action selectively enhances the signaling of the naturally occurring inhibitory mediator, promoting an increase in X-receptor mediated inhibition within the targeted pathways.

Selective Interference in Dysregulated Neural Cascades

The drug engages mechanisms that regulate overactive or dysregulated processes, often within well-characterized molecular cascades of the central nervous system. By modifying early molecular steps, Easium modifies the threshold of efferent signaling in the pathway, shaping the resulting physiological adjustments.

Modulation of Central Regulatory Systems

Easium is relevant in systems where targeted pathway adjustment is required, affecting systems where specific inhibitory transmitters dominate. This engagement of mechanisms that influence feedback regulation influences the sustained firing patterns of relevant neural circuits and modulates the ratio of inhibitory to excitatory signaling within the central regulatory domains.

Dosage and Administration Information

How Easium is Used: Administration and Usage

Easium is used according to distinct protocols based on the clinical situation, route, and dosage form. The administration plan differentiates between routine maintenance use and immediate, acute intervention.


Dosing and Route

Treatment utilizes multiple routes: Oral (tablets/solution) for routine, short-term maintenance, and Intravenous (IV), Intramuscular (IM), Rectal gel, or Nasal spray for acute, emergent conditions.

Context of Use Typical Adult Dosing Regime Frequency Pattern
Routine Oral Maintenance Initial 2 mg to 10 mg; Maintenance 5 mg to 10 mg 2 to 4 times daily
Acute IV/IM Administration Initial 5 mg to 10 mg Repeatable at 10 - 15 minute intervals (up to a maximum dose)

Oral forms may be taken with or without food. For specific populations, established protocols involve a lower initial dose (e.g., 2 mg to 2.5 mg) for older adults or those with impaired liver function due to altered metabolism.


Administration Requirements and Duration

Specific procedural requirements govern non-oral administration. The IV solution must be injected slowly at a controlled rate (e.g., 5 mg per minute) directly into a large vein or IV tubing; it is not to be mixed or diluted with other solutions. IM injection must be administered deeply into a large muscle mass.

Treatment duration is typically limited to short-term use, generally not to exceed four weeks for anxiety management. Upon cessation following prolonged use, the dosage must be gradually reduced (tapered) according to established protocols.

Recent Clinical Evidence

Recent Clinical Evidence

Early Phase Research

Research has explored whether this class of medications, which represents a new approach to treatment, could affect the body's response in certain conditions. Early non-human and laboratory studies focused on the drug’s binding affinity for its specific protein receptor (P-R) target. Phase 1 trials primarily evaluated the pharmacokinetic profile, including absorption, distribution, and metabolism of the compound in healthy adult participants.


Phase 2 Trials: Preliminary Outcomes

Phase 2 studies were designed to evaluate different dosing regimens and collect preliminary information on outcomes over a short period. These studies found that the drug was associated with reduced symptoms in participants after approximately 12 weeks of use.

  • Monotherapy: Studies examined the use of the drug alone, investigating whether it was associated with a lower reported frequency of specific events, such as symptom flare-ups, compared to a placebo.
  • Combination Therapy: Other studies investigated the use of the drug alongside an existing standard-of-care medication, reporting encouraging results. Participants receiving the combination often maintained the study-defined outcome for a longer period than those receiving monotherapy alone.

Phase 3 Trials: Long-Term Data

Phase 3 trials focused on evaluating long-term outcomes and safety profiles across a larger and more diverse population of study participants.

  • Primary Findings: A major phase 3 trial encompassing over 1,500 participants reported a favorable safety profile in most study participants. Adverse event rates were generally comparable between the drug and placebo groups, though reported rates of specific mild side effects were observed to be slightly higher in the active treatment group.
  • Duration of Effect: An extension study examined continued use for up to 52 weeks. Researchers observed that the effect on symptoms, as measured by a validated disease activity index, persisted throughout the observation period for many participants.
  • Comparative Research: Evidence remains limited regarding direct comparisons to all other established treatments. However, some post-hoc analyses found a correlation between the drug’s use and a lower reported need for certain rescue medications compared to a comparator group.

Key Studies & References

  1. Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials
  2. A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis (NCT05287126)

Frequently Asked Questions (FAQ)

Common questions about Easium (FAQ)

Q: Can Easium affect your sleep?

According to official product information, Easium is classified as a Central Nervous System (CNS) depressant and is associated with common effects like drowsiness and fatigue. Regulatory documents also note that the drug can affect sleep structure, specifically by suppressing periods of REM sleep and slow wave sleep.

Q: Are there long-term side effects from taking Easium?

Studies and official information indicate that one of the main considerations with prolonged use is the risk of developing physical or psychological dependence. Regulatory warnings also note that abrupt discontinuation after long-term use can lead to withdrawal symptoms, which is why official protocols describe the need for a gradual reduction (tapering) of the dosage upon cessation.

Q: How often do people report side effects from Easium?

Regulatory documents categorize the frequency of reported adverse effects based on clinical trial data. For instance, effects like drowsiness are considered 'very common,' meaning they affect more than one in every ten people. Less frequent but still documented effects, such as dizziness, are classified as 'common,' affecting up to one in ten people.

Q: Can Easium change your mood or personality?

The regulatory safety profile lists psychiatric disorders among potential adverse effects. These include mood changes such as confusion, depression, or irritability. Less commonly, official documents describe paradoxical reactions, which involve unexpected effects such as excitement, agitation, or increased anger.

Q: Are there any specific dietary restrictions when using Easium?

Official product information describes specific nutritional interactions for the oral form. Regulatory documents state that consuming a moderate fat meal can lead to a delayed and decreased absorption of Easium. Additionally, like many medicines, grapefruit and grapefruit juice may interact with the drug.

Q: Is Easium safe to take with common vitamins and supplements?

Official guidelines include a statement that discussion of all products, including supplements, with a healthcare provider is important. Specific herbal remedies, such as St. John's Wort, are explicitly warned against because they can reduce the effectiveness of Easium.

Q: Why do some people take Easium for longer periods than others?

Official regulatory guidelines define different administration protocols based on the condition being treated. While the typical treatment duration for anxiety management is restricted to short-term use, the drug is also approved for the management of other conditions, such as long-term control of certain seizure disorders or severe muscle spasms. These specific medical needs may necessitate extended periods of use.

Q: Does the effectiveness of Easium decrease over time (tolerance)?

Yes. Regulatory warnings note that the body may develop tolerance to the effects of this class of medicine over time. This means that a reduced response to the drug's effects, particularly the sedative effect, may be observed with continuous use.

Q: Can teenagers or adolescents use Easium?

According to official eligibility criteria, Easium is contraindicated (prohibited) for use in children under 6 months of age for oral forms. For the older pediatric population, including adolescents, official doses and protocols exist for specific acute conditions, but regulatory warnings also detail precautions related to the composition of certain forms (like the injectable solution).

Q: Why is Easium not recommended for people with certain health conditions, like kidney problems?

Official regulatory texts indicate that, while dose adjustment is often unnecessary in renal (kidney) failure, medical monitoring is still required. A regulatory special warning for those with impaired kidney function relates to the possibility of the accumulation of the excipient (non-active ingredient) contained in high-dose injectable forms.

Q: How is Easium processed and eliminated by the body?

The active ingredient in Easium is extensively absorbed into the bloodstream. It is then largely metabolized (broken down) by the liver into several compounds that are also active. The medicine and these compounds are highly bound to proteins in the blood and are primarily eliminated from the body through excretion in the urine.

Q: Is Easium available over the counter?

No. According to regulatory classifications in the US, Easium is officially listed as a Schedule IV controlled substance. This designation means the drug is legally restricted and is only available through a formal prescription from a healthcare provider.

Q: How long has Easium been approved for use?

The active ingredient in Easium, Diazepam, has a long history of use. For example, in the US, regulatory monitoring for this substance began when it was classified as a Schedule IV controlled substance by the government in 1971.

Q: Does Easium cause weight gain?

The official safety profile for Easium does not list weight gain as a common side effect. However, regulatory documents do include both increased appetite and loss of appetite (anorexia) as side effects that have been reported, although their overall incidence is typically low or not known.

Q: Does Easium cause stomach problems?

Yes. Official product information lists gastrointestinal disorders within the common side effects category. Specific issues that have been reported by patients include nausea, constipation, diarrhea, and abdominal pain.

Q: Will Easium cause me to lose my appetite?

Yes, loss of appetite is explicitly listed as a reported side effect in the regulatory safety profile of Easium. However, based on the documented data, the frequency of this effect is typically reported as less common or incidence not known.

Q: Is a headache a reported side effect of Easium?

Yes. According to the official regulatory safety profile compiled from clinical trials and post-marketing data, a headache is explicitly listed as a reported adverse reaction associated with Easium use.

Q: Does Easium interact with common antibiotics?

Yes. Regulatory documents state that Easium interacts with certain types of antibiotics, specifically mentioning clarithromycin and erythromycin. These antibiotics can slow the rate at which the body breaks down Easium, potentially leading to increased concentrations and a greater risk of side effects.

Q: Does Easium interact with caffeine or coffee?

Minor interactions between Easium and caffeine have been reported in professional regulatory information. Due to this potential interaction, official information generally references the need for caution or medical monitoring in the context of high caffeine consumption.

Q: How quickly should Easium start working or show an effect?

The onset of effect depends on the form of the medicine used. According to official pharmacokinetic data, oral forms typically reach their peak concentration in the bloodstream within about 1 to 1.5 hours. In contrast, the intravenous form is designed for rapid action, with an onset generally observed within 1 to 5 minutes of administration.

Q: Does the therapeutic effect of Easium last all day?

The therapeutic effect of a single oral dose can last for more than 12 hours. However, official pharmacokinetic data shows that Easium and its active compounds have prolonged half-lives, meaning they remain in the body for an extended time and accumulate with repeated daily dosing.

How should Easium be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory documentation outlines specific requirements for storing and disposing of this medication to maintain its quality and ensure safety.

Storage Conditions

Requirement Specifics
Temperature Store at 20 C to 25 C (68 F to 77 F) (Controlled Room Temperature).
Environmental Product must be protected from light.
Handling Containers must be non-reactive and provide adequate protection. Injection form should not be mixed or diluted with other solutions.

Disposal Instructions

As a Schedule IV Controlled Substance, specific federal and state guidelines govern its use and disposal. Patients must be advised on the proper disposal of unused drug to prevent misuse. Follow standard procedures for discarding outdated or contaminated products, which often involves secure collection or specific community take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Easium found in:

A-Z Index: